Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation

Severe acute respiratory syndrome coronavirus 2 cell entry depends on angiotensin-converting enzyme 2 and transmembrane serine protease 2 and is blocked in cell culture by camostat mesylate, a clinically proven protease inhibitor. Whether camostat mesylate is able to lower disease burden in coronavi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofmann-Winkler, Heike, Moerer, Onnen, Alt-Epping, Sabine, Bräuer, Anselm, Büttner, Benedikt, Müller, Martin, Fricke, Torben, Grundmann, Julian, Harnisch, Lars-Olav, Heise, Daniel, Kernchen, Andrea, Pressler, Meike, Stephani, Caspar, Tampe, Björn, Kaul, Artur, Gärtner, Sabine, Kramer, Stefanie, Pöhlmann, Stefan, Winkler, Martin Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671878/
https://www.ncbi.nlm.nih.gov/pubmed/33225308
http://dx.doi.org/10.1097/CCE.0000000000000284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671878/
https://www.ncbi.nlm.nih.gov/pubmed/33225308
http://dx.doi.org/10.1097/CCE.0000000000000284

Ejemplares similares